With humanitarian funding slashed by the US and other countries, this year’s global health headlines have made grim reading. First new type of malaria treatment in decadesAfter successful clinical trials, the first new type of malaria treatment in decades is to seek regulatory approval. GanLum, from pharma company Novartis, outperformed the standard treatment by demonstrating a cure rate of 99.2% compared with 96.7% from the standard treatment. Crucially, it should also be effective against malaria parasites that have developed resistance to artemisinin — a component of the current standard treatment. In the 1990s, resistance to chloroquine, then the standard malaria treatment, led to millions of deaths, says Dr George Jagoe of the Medicines for Malaria Venture.

Source: Irish Examiner December 27, 2025 15:00 UTC